Covid-19: See latest data on suppliers and inventory

AN2 THERAPEUTICS logo

AN2 THERAPEUTICS

Claimed
171 Forest Ln, Menlo Park, CA 94025, United States
MCDC
AN2 Therapeutics, Inc. specifies their major offering areas as: Modern Biomedical, Drug, and Small Molecule Therapeutics Research and Development Infectious Diseases.
DUNS #:
080615335
CAGE Code:
822Z2
Type:
Services Provider
Employees:
1-10
Annual Revenue:
Less than $1M
Year Founded:
2017
Country of Origin:
United States
Sectors Served:
US Federal, Private Sector
Company Security Level:
Unknown
Credit Card Usage:
Unknown

Specialties and Expertise:

Small Molecule Therapeutics, Modern Biomedical Development, Drug Development, Infectious Disease Drug.

Contact Info2

Size and minority status

Size
Small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

PRODUCTS AND SERVICES1

Therapeutics Research & Development
1 past experience
AN2 Therapeutics is focused on the research and development of modern biomedical and drugs to provide transformational medicines for infectious diseases.

Past experience1

other
AN2 Therapeutics announced $12 Million in S...
AN2 Therapeutics raised $12 million in a Series A financing led by Mountain Group Partners and joined by Adjuvant Capital, Brii Bios...

Existing Contracts2

Contract Vehicle Type
Contract Name
Contract #
Who Can Use
Managing Organization
Exp. Date
no data
MCDC
W15P7T-18-9-0001
All DoD
MCDC
Apr 07, 2036
Other Programs
Medical CBRN Defense Consortium (MCDC)
W15P7T-18-9-0001
All DoD
ACC-APG
Jul 04, 2036

Locations served1

  • United States 1 location
My Notes
Contact
My Notes